Skip to main content
SpringerLink
Log in
Book cover

Stereotactic Body Radiation Therapy pp 211–225Cite as

Gynecologic Cancer

  • Chapter

  • 2202 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Gynecologic cancers are leading causes of death in women worldwide. When relapse occurs after initial treatment, the use of conventional radiation therapy is difficult due to relative intolerance of normal tissue to further therapy. Stereotactic body radiation therapy (SBRT) has emerged as at least one means to provide sterilizing doses of radiation among tissues that have received previous irradiation or exposed to many courses of chemotherapy. Clinical experience with SBRT now demonstrates the safety and efficacy of this treatment modality. Technical aspects, treatment parameters, management of toxicity, and comments on future directions of SBRT for gynecologic cancer management are discussed.

Authors’ Contributions

C.A. Kunos, J. Fabien, Y. Zhang, J. Brindle, and N.A. Mayr made substantial contributions to the conception, design, drafting, and writing of this book chapter. This book chapter has been seen, read, and agreed upon in its content by all the designated authors.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Acs G, Zhang P, McGrath C, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A (2003) Hypoxia-inducible erythropoietin singaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162(6):1789–1806

    Article  PubMed  CAS  Google Scholar 

  • Adriaens I, Smitz J, Jacquet P (2009) The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update 15(3):359–377

    Article  PubMed  CAS  Google Scholar 

  • American Cancer Society (2010) Cancer Facts & Figures 2010. American Cancer Society, Atlanta

    Google Scholar 

  • Antypas C, Pantelis E (2008) Performance evaluation of a CyberKnife® G4 image-guided robotic stereotactic radiosurgery system. Phys Med Biol 53:4697–4718

    Article  PubMed  Google Scholar 

  • Benedict S, Cardinale R, Wu Q, Zwicker R, Broaddus W, Mohan R (2001) Intensity-modulated stereotactic radiosurgery using dynamic micro-multileaf collimation. Int J Radiat Oncol Biol Phys 50(3):751–758

    Article  PubMed  CAS  Google Scholar 

  • Bernhard E, Stanbridge E, Gupta S et al (2000) Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines. Cancer Res 60:6597–6600

    PubMed  CAS  Google Scholar 

  • Branca M, Ciotti M, Santini D, Di Bonito L, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A et al (2004) Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Am J Clin Pathol 122:902–911

    Article  PubMed  CAS  Google Scholar 

  • Chiao TB, Lee AJ (2005) Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Ann Pharmacother 39(3):516–522

    Article  PubMed  CAS  Google Scholar 

  • Choi C, Cho C, Yoo S, Kim M, Yang K, Yoo H, Seo W, Kang J, Lee D, Lee K et al (2009) Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 74(1):147–153

    Article  PubMed  Google Scholar 

  • Chung E, Brown A, Asano H, Mandler M, Burgan W, Carter D, Camphausen K, Citrin D (2009) In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-related kinase 1/2 kinase. Clin Cancer Res 15(9):3050–3057

    Article  PubMed  CAS  Google Scholar 

  • Deodata F, Macchia G, Grimaldi L, Ferradina G, Lorusso D, Salutari V, Cilla S, Valenti V, Cellini N, Piermattei A et al (2009) Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep 22(2):415–419

    Google Scholar 

  • Dickens C (1981) Personalized fixation using a vacuum consolidation technique. Br J Radiol 54:257–258

    Article  PubMed  CAS  Google Scholar 

  • Du X, Jiang T, Wen Z, Li Q, Gao R, Wang F (2009) Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities. Oncol Rep 21:625–634

    PubMed  CAS  Google Scholar 

  • Duenas-Gonzalez A, Zarba J, Patel F, Alcedo J, Beslija F, Casanova L, Pattarunataporn P, Hameed S, Blair J, Barraclough H et al (2011) A phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol 29(13):1678–1685

    Article  PubMed  CAS  Google Scholar 

  • Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, Haensgen G (2003) Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56(3):778–787

    Google Scholar 

  • Echner G, Kilby W, Lee M, Earnst E, Sayeh S, Schlaefer A, Rhein B, Dooley J, Lang C, Blank O et al (2009) The design, physical properties and clinical utility of an iris collimator for robotic radiosurgery. Phys Med Biol 54:5359–5380

    Article  PubMed  CAS  Google Scholar 

  • Eklund H, Uhlin U, Farnegardh M, Logan DT, Nordlund P (2001) Structure and function of the radical enzyme ribonucleotide reductase. Prog Biophys Mol Biol 77(3):177–268

    Article  PubMed  CAS  Google Scholar 

  • Feldmeier J (2008) Hyperbaric oxygen therapy for delayed radiation injuries. In: Neuman T, Thom S (eds) Physiology and medicine of hyperbaric oxygen therapy. Saunders Elsevier, Philadelphia, pp 231–256

    Chapter  Google Scholar 

  • Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D (2010) GLOBOCAN 2008 Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer http://globocon.iarc.fr

  • Ferrandina G, Mey V, Nannizzi S, Ricciardi S, Petrillo M, Ferlini C, Danesi R, Scambia G, Tacca M (2010) Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine enzymes in primary ovarian cancer. Cancer Chemother Pharmacol 65(4):679–686

    Article  PubMed  CAS  Google Scholar 

  • Fowler J (2010) 21 years of biologically effective dose. Br J Radiol 83(991):554–568

    Article  PubMed  CAS  Google Scholar 

  • Fowler J, Tome W, Fenwick J, Mehta M (2004a) A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60(4):1241–1256

    Article  PubMed  Google Scholar 

  • Fowler J, Welsh J, Howard S (2004b) Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 59(1):242–249

    Article  PubMed  Google Scholar 

  • Gardner L, Li Q, Park M, Flanagan W, Semenza G, Dang C (2001) Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 276:7919–7926

    Article  PubMed  CAS  Google Scholar 

  • Gerszten P, Novotny JJ, Quader M, Dewald V, Flickinger J (2010) Prospective evaluation of a dedicated spine radiosurgery program using the Elekta Synergy S system. J Neurosurg 113 Suppl:236–241.

    Google Scholar 

  • Goda N, Ryan H, Khadivi B, McNulty W, Rickert R, Johnson R (2003) Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia. Mol Cell Biol 23(1):359–369

    Article  PubMed  CAS  Google Scholar 

  • Gothard L, Cornes P, Brooker S, Earl J, Glees J, Hall E, Peckitt C, Tait D, Yarnold J (2005) Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol 75(3):334–341

    Article  PubMed  CAS  Google Scholar 

  • Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19(17):3745–3749

    PubMed  CAS  Google Scholar 

  • Hall EJ (2000) Radiobiology for the radiologist. Lippincott Williams & Wilkins: Philadelphia. p 588

    Google Scholar 

  • Hall EJ, Hei TK (2003) Genomic instability and bystander effects induced by high-LET radiation. Oncogene 22(45):7034–7042

    Article  PubMed  CAS  Google Scholar 

  • Higginson D, Morris D, Jones E, Clarke-Pearson D, Varia M (2011) Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology. Gynecol Oncol 120(3):404–412

    Article  PubMed  Google Scholar 

  • Holmes W, Soprano D, Soprano K (2003) Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene 22:6377–6386

    Article  PubMed  CAS  Google Scholar 

  • Homesley H, Filiaci V, Gibbons S, Long H, Cella D, Spiritos N, Morris R, DeGeest K, Lee R, Montag A (2009) A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecol Oncol 112(3):543–552

    Article  PubMed  CAS  Google Scholar 

  • Hoogeman M, Prévost J-B, Nuyttens J, Pöll J, Levandag P, Heijmen B (2009) Clinical Accuracy of the Respiratory Tumor Tracking System of the Cyberknife: Assessment By Analysis of Log Files. Int J Radiat Oncol Biol Phys 74(1):297–303

    Article  PubMed  Google Scholar 

  • Hsu C-Y, Bristow R, Cha M, Wang B, Ho C-L, Kurman R, Wang T-L, Shih I-M (2004) Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res 10:6432–6436

    Article  PubMed  CAS  Google Scholar 

  • Kamei H, Jackson R, Zheleva D, Davidson F (2010) An integrated pharmacokinetic-pharmacodynamic model for an Aurora kinase inhibitor. J Pharmacokinet Pharmacodyn 37:407–434

    Article  PubMed  CAS  Google Scholar 

  • Karlsson A, Helou K, Walentinsson A, Hedrich H, Szpirer C, Levan G (2001) Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Genes Chromosom Cancer 31(4):345–356

    Article  PubMed  CAS  Google Scholar 

  • Kilby W, Dooley J, Kuduvalli G, Sayeh S, Maurer C (2010) The Cyberknife robotic radiosurgery system in 2010. Technol Cancer Res Treat 9(5):431–438

    Google Scholar 

  • Kim Y, Kim J, Jeong K, Seong J, Suh C, Kim G (2009) Dosimetric comparisons of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy in whole abdominopelvic radiotherapy for gynecologic malignancy. Technol Cancer Res Treat 8(5):369–377

    PubMed  Google Scholar 

  • Kolberg M, Strand KR, Graff P, Andersson KK (2004) Structure, function, and mechanism of ribonucleotide reductases. Biochim Biophys Acta 1699(1–2):1–34

    PubMed  CAS  Google Scholar 

  • Kunos C, Von Gruenigen V, Waggoner S, Brindle J, Zhang Y, Myers B, Funkhouser G, Wessels B, Einstein D (2008) Cyberknife radiosurgery for squamous cell carcinoma of the vulva after prior pelvic radiation therapy. Technol Cancer Res Treat 7(5):375–380

    PubMed  Google Scholar 

  • Kunos C, Chen W, DeBernardo R, Waggoner S, Brindle J, Zhang Y, Williams J, Einstein D (2009a) Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies. Technol Cancer Res Treat 8(5):393–400

    PubMed  Google Scholar 

  • Kunos C, Chiu S, Pink J, Kinsella T (2009b) Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein. Radiat Res 172(6):666–676

    Article  PubMed  CAS  Google Scholar 

  • Kunos C, Sill M, Waggoner S, Fracasso P (2009c) A phase 1 study using low dose abdominal radiation as a docetaxel chemosensitizer for recurrent, persistent or advanced ovarian, peritoneal, or fallopian tube cancer. Gynecol Oncol (in press)

    Google Scholar 

  • Kunos C, Radivoyevitch T, Pink J, Chiu S, Stefan T, Jaccobberger J, Kinsella T (2010) Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers. Radiation Res 174(5):574–581

    Article  PubMed  CAS  Google Scholar 

  • Kunos C, Brindle J, Zhang Y, DeBernardo R (2011) A prospective phase 2 evaluation of stereotactic body radiosurgery for gynecologic malignancies. Cyberknife Robotic Radiosurgery Summit February 12, San Francisco, CA

    Google Scholar 

  • Lee Y, Park N, Kim J, Song Y, Kang S, Lee H (2008) Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol 108(3):505–509

    Article  PubMed  Google Scholar 

  • Mackie T, Holmes T, Swerdloff S, Reckwerdt P, Deasy J, Yang J, Paliwal B, Kinsella T (1993) Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20(6):1709–1719

    Article  PubMed  CAS  Google Scholar 

  • Markman M (2006) Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer. Semin Oncol 33 (6 (Suppl 12)):S3–S7

    Google Scholar 

  • Monk B, Sill M, McMeekin D, Cohn D, Ramondetta L, Boardman C, Benda J, Cella D (2009) Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study. J Clin Oncol 27(28):4649–4655

    Article  PubMed  CAS  Google Scholar 

  • Munro T (1970) The relative radiosensitivity of the nucleus and cytoplasm of the Chinese hamster fibroblast. Radiat Res 42:451–470

    Article  PubMed  CAS  Google Scholar 

  • Murphy J, Christman-Skieller C, Kim J, Dietrich S, Chang D, Koong A (2010) A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 78(5):1420–1426

    Article  PubMed  Google Scholar 

  • Ozhasoglu C, Saw C, Hungcheng C, Burton S, Komanduri K, Huq S, Heron D (2008) Synchrony–Cyberknife Respiratory Compensation Technology. Med Dosimetry 33(2):117–123

    Article  Google Scholar 

  • Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R et al (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study. J Clin Oncol 21(17):3194–200

    Article  PubMed  CAS  Google Scholar 

  • Park C, Papiez L, Zhang S, Story M, Timmerman R (2008) Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70(3):847–852

    Article  PubMed  Google Scholar 

  • Piao C, Jin M, Lee S, Amatya P, Hyun J-W, Chang I-Y, You H (2009) Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2. Oncogene 28:2173–2184

    Article  PubMed  CAS  Google Scholar 

  • Pollock P, Gartside M, Dejeza L et al (2007) Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 26:7158–7162.

    Google Scholar 

  • Randall M, Filiaci V, Spirtos N, Mannel R, Fowler J, Thigpen J, Benda J (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24(1):36–44

    Article  PubMed  CAS  Google Scholar 

  • Rochet N, Sterzing F, Jensen A, Dinkel J, Herfarth K, Schubert K, Eichbaum M, Schneeweiss A, Sohn C, Debus J et al (2008) Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 184(3):145–149

    Article  PubMed  Google Scholar 

  • Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17(1):41–45

    PubMed  CAS  Google Scholar 

  • Rose P, Ali S, Watkins E, Thigpen J, Deppe G, Clark-Pearson D, Insalaco S (2007) Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a gynecologic oncology group study. J Clin Oncol 25(19):2804–2810

    Article  PubMed  CAS  Google Scholar 

  • Schwartz J, Siegel B, Dehdashti F, Grigsby P (2007) Association of post-therapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298(19):2289–2295

    Article  Google Scholar 

  • Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metases: Final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47(2):291–298

    Article  PubMed  CAS  Google Scholar 

  • Shenouda G, Mehio A, Souhami L, Duclos M, Portelance L, Belenkov A, Chow T (2006) Erythropoietin receptor expression in biopsu specimens from patients with uterine cervix squamous cell carcinoma. Int J Gynecol Cancer 16(2):752–756

    Article  PubMed  CAS  Google Scholar 

  • Sherouse G, Bourland J, Reynolds K et al (1990) Virtual simulation in the clinical setting: some practical considerations. Int J Radiat Oncol Biol Phys 19:1059–1065

    Article  PubMed  CAS  Google Scholar 

  • Sklar M (1988) The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239:645–647

    Article  PubMed  CAS  Google Scholar 

  • Swamidas V, Mahantshetty U, Goel V, Engineer R, Deshpande D, Sarin R, Shrivastava S (2009) Treatment planning of epithelial ovarian cancers using helical tomotherapy. J Appl Clin Med Phys 10(4):96–105

    Article  Google Scholar 

  • Thomas G, Ali S, Hoebers F, Darcy K, Rodgers W, Patel M, Abulafia O, Lucci Jr, Begg A (2008) Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol 108(2):317–325.

    Google Scholar 

  • Wang J, Huang H, Lo S, Yuh W, Mayr N (2010) A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med 2(39):39–48

    Article  Google Scholar 

  • Wilcox E, Daskalov G (2007) Evaluation of GAFCHROMIC EBT film for Cyberknife® dosimetry. Med Phys 34(6):1967–1974

    Article  PubMed  CAS  Google Scholar 

  • Winter Wr, Maxwell G, Tian C, Sobel E, Rose G, Thomas G, Carlson J (2004) Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 94(2):495–501

    Article  PubMed  CAS  Google Scholar 

  • Wunderink W, Mendez Romero A, de Kruijf W, de Boer H, Levendag P, Heijmen B (2008) Reduction of respiratory liver tumor motion by abdominal compression in stereotactic body frame, analyzed by tracking fiducial markers implanted in liver. Int J Radiat Oncol Biol Phys 71(3):907–915

    Article  PubMed  Google Scholar 

  • Yeh T, Marsh V, Bernat B et al (2007) Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor. Clin Cancer Res 13:1576–1583

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

There are no potential conflicts of interest among the authors and this manuscript. There are no financial or non-financial competing interests. This manuscript has been seen, read, and agreed upon in its content by all the designated authors. This manuscript has not been submitted or published elsewhere.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology and Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA

    Charles A. Kunos, Jeffrey Fabien, Yuxia Zhang & James Brindle

  2. Department of Radiation Oncology, Arthur G. James Cancer Hospital, Ohio State University College of Medicine, Columbus, OH, 43210, USA

    Nina A. Mayr

  3. Department of Radiation Oncology, University Hospitals of Cleveland, 11100 Euclid Avenue, LTR 6068, Cleveland, OH, 44106, USA

    Charles A. Kunos

Authors
  1. Charles A. Kunos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey Fabien
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuxia Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Brindle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nina A. Mayr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles A. Kunos .

Editor information

Editors and Affiliations

  1. , Department of Radiation Oncology, Case Western Reserve University, Euclid Avenue 11100, Cleveland, 44106, Ohio, USA

    Simon S. Lo

  2. , Department of Radiation Oncology, Weil Cornell Medical College, Fannin, Ste#DB1-077 6565, Houston, 77030, Texas, USA

    Bin S. Teh

  3. Cancer Institute, Department of Radiation Oncology, National University Hospital, Lower Kent Ridge Road 5, Singapore, 119074, Singapore

    Jiade J. Lu

  4. , Department of Radiation Oncology, University of Colorado, Aurora, 80045, Colorado, USA

    Tracey E. Schefter

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kunos, C.A., Fabien, J., Zhang, Y., Brindle, J., Mayr, N.A. (2011). Gynecologic Cancer. In: Lo, S., Teh, B., Lu, J., Schefter, T. (eds) Stereotactic Body Radiation Therapy. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_439

Download citation

  • DOI: https://doi.org/10.1007/174_2011_439

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-25604-2

  • Online ISBN: 978-3-642-25605-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation